Proto-oncogene c-kit expression in malignant melanoma: Protein loss with tumor progression

Modern Pathology

Volumn 10, Issue 9, 1997, Pages 939-944

  Montone, Kathleen T ^a   Van Belle, Patricia ^a   Elenitsas, Rosalie ^a   Elder, David E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C kit; Melanoma; Proto oncogenes; Tumor progression

Indexed keywords

MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR GROWTH;

DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTES; MELANOMA; MODELS, BIOLOGICAL; NEVUS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS;

EID: 0030765407     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yarden Y, Kuang WS, Yang-Feng T, Coussens L, Munemitsas S, Dull TJ, et al. Human proto-oncogene c-kit, a new cell surface-receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-51.
2. Zsebo KM, Williams DA, Geissler EN, Broudy WL, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the SI locus of the mouse and is ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-24.
3. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-74.
4. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, et al. c-kit kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulated mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992;3:197-209.
5. Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A, Ulrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 1992;52(2):197-201.
6. Larue L, Dougherty N, Porter S, Mintz B. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a kit kinase-domain mutation. Proc Natl Acad Sci U S A 1992;89:7816-20.
7. Lassam N, Bickford S. Loss of c-kit expression in cultured melanoma cells. Oncogene 1992;7:51-6.
8. Yoshida H, Nishikawa S-I, Okamura H, Sakakura T, Kusakabe M. The role of c-kit proto-oncogene during melanocyte development in mouse. In vivo approach by the in utero microinjection of anti-c-kit antibody. Dev Growth Differ 1993;35:209-20.
9. Zakut R, Perlis R, Eliyahu S, Yarden Y, Givol D, Lyman SD, et al. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cell lines. Oncogene 1993;8:2221-39.
10. Geissler EN, Ryan MA, Housman DE. The dominant white spotting (w) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988;55:185-92.
11. Spritz RA, Holmes SA, Itin P, Kuster W. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. J Invest Dermatol 1993;101:22-5.
12. Tsuura Y, Hiraki H, Watanabe K, Igarashi S, Shimamura K, Fukuda T, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in humans: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Archiv 1994;424:135-41.
13. Gutman M, Singh RK, Radinsky R, Bar-Eli M. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res 1994;14:1759-65.
14. Elder DE, Clark WH Jr, Elenitsas R, Guerry D IV, Halpern AC. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993;10: 18-35.
15. Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, et al. Model for predicting survival in stage 1 melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-904.
16. Elder DE, Murphy GF. Melanocytic tumors of the skin. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology. 3rd Series, Fascicle 2. Washington, D.C.: Armed Forces Institute of Pathology; 1991. p. 103-30.
17. Wang JY, Montone KT. A rapid simple in situ hybridization method for herpes simplex virus employing a synthetic biotin labeled oligonucleotide probe: a comparison with immunohistochemical methods for HSV detection. J Clin Lab Anal 1994;8:105-15.
18. Herlyn M. Structure and function of molecules produced by melanoma cells. In: Herlyn M, editor. Molecular and cellular biology of melanoma. Austin: R.G. Landes; 1993. p. 44-92.
19. Kinashi T, Springer TA. Steel factor and c-kit regulate cell-matrix adhesion. Blood 1994;83:1033-8.
20. Danen EHJ, Ten Berge PJM, Van Muijen GNP, Van't Hof-Grootenboer AE, Bröcker EB, Ruiter DJ. Emergence of α5β1 fibronectin- and αvβ3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology 1994;24: 249-56.